RE:1.45
Trying to establish an actual value on the shares of TauRx owned by Dundee is a biy of a challenge.
According to Jonathan Goodman "Dundee holds 1,015,008 shares in TauRx, representing a 3.2% interest in the company. Dundee Corporation determined that the fair value of its investment in TauRx at September 30, 2022, was $38.5 million, or USD$27.69 per share."
Now, the most recent financing at YauRx was made lasy month at US$45.00 per share through excercise of warrants obtained in previous 2021 financing (Dundee did not participate).
According to two October articles in financial newspaper/magazines in Malaysia "“From other channel checks, we understand that TauRx shares are now transacting at a much higher US$200-US$300 each. We are told that since not all shareholders participated in the aforementioned rights issue and thus, did not receive the warrants,"
If we use US$200 per share value, we get US$ 203,000,00 or Cdn$ 255,000,000 or almost Cdn$ 3.00 per share.
Full disclosure: my wife and I are shareholders of both common and preferred shares